6533b7d5fe1ef96bd1263cf4
RESEARCH PRODUCT
Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind
Rafael De La EspriellaJulio NúñezAntoni Bayes-genissubject
Heart Failuremedicine.medical_specialtybusiness.industrymedicine.diseaseRenin-Angiotensin SystemInternal medicineHeart failureCardiologyHumansMedicineNeprilysinCardiology and Cardiovascular MedicinebusinessNeprilysinRandomized Controlled Trials as Topicyear | journal | country | edition | language |
---|---|---|---|---|
2020-02-01 | International Journal of Cardiology |